Skip to Main content Skip to Navigation

Cytochrome P450 and inflammation : pharmacogenomic approach and molecular aspects of anti-inflammatory effects of theinopyridines

Abstract : The main part of the thesis is devoted to pharmacogenetic approach to the anti-inflammatory effects of thienopyridine therapy. Taking into the account that activated platelets play a central role in the inflammatory responses and that CYP2C19 gain- and loss-of-function polymorphisms (*2 and *17) are sources of inter-individual difference in response to the anti-platelet effects of thienopyridines, we hypothesized that *2 and/or *17 alleles are also associated with inter-individual variability in the potential inflammation-reducing effects of thienopyridines. The following markers were used to test the hypothesis: CRP, haptoglobin and orosomucoid acid. To be reliably interpretable in daily medical practice, genetic status should be considered for partitioning the reference values of haptoglobin. In a small healthy population, no significant association was observed between *2 allele and changes in levels of inflammatory markers from baseline to 7 days after administration of clopidogrel and our findings did not support the notion that the genetic variations of CYP epoxygenases are associated with the level of inflammatory markers. Also, in post-PCI population consisting of 1128 on-clopidogrel or on-prasugrel patients, CRP levels were observed to be regulated with a significant interaction between smoking and CYP2C19 polymorphisms; this effect was independent to the level of platelet aggregation. Additionally, in a large population of 1000 on-clopidogrel patients, whether there is a potential interaction between clopidogrel and calcium channel blockers. Collectively, we demonstrated in this thesis that inflammatory markers might be alternative tools for the prediction of response to thienopyridines
Document type :
Complete list of metadata
Contributor : Thèses Ul Connect in order to contact the contributor
Submitted on : Thursday, March 29, 2018 - 12:51:43 PM
Last modification on : Monday, October 19, 2020 - 11:10:29 AM


Files produced by the author(s)


  • HAL Id : tel-01750660, version 1



Payman Shahabi. Cytochrome P450 and inflammation : pharmacogenomic approach and molecular aspects of anti-inflammatory effects of theinopyridines. Human health and pathology. Université de Lorraine, 2013. English. ⟨NNT : 2013LORR0320⟩. ⟨tel-01750660⟩



Record views


Files downloads